Gene regulation with polyvalent siRNA-nanoparticle conjugates
about
Noble metal nanoparticles applications in cancerGold nanoparticle contrast agents in advanced X-ray imaging technologiesSafe clinical use of carbon nanotubes as innovative biomaterialsDelivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles.High-Density Lipoproteins: Nature's Multifunctional NanoparticlesProgress toward in vivo use of siRNAs-IIComposite nanoparticles for gene delivery.Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: potential for targeting experimental brain tumors.Delivery of cancer therapeutics using nanotechnologyNovel Methods of Enhanced Retention in and Rapid, Targeted Release from Liposomes.Oligothiol graft-copolymer coatings stabilize gold nanoparticles against harsh experimental conditions.Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastomaAntitumor therapeutic application of self-assembled RNAi-AuNP nanoconstructs: Combination of VEGF-RNAi and photothermal ablation.Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery.Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.Gold nanoparticles for biology and medicine.The smart targeting of nanoparticlesTailoring DNA structure to increase target hybridization kinetics on surfaces.Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte.Relationships between Poly(ethylene glycol) Modifications on RNA-Spherical Nucleic Acid Conjugates and Cellular Uptake and Circulation Time.Gold nanoparticles for nucleic acid delivery.Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.High-density lipoproteins for the systemic delivery of short interfering RNA.Trigger-Responsive Gene Transporters for Anticancer Therapy.Modular and Chemically Responsive Oligonucleotide "Bonds" in Nanoparticle Superlattices.Gold nanoparticles: preparation, properties, and applications in bionanotechnologySurface functionalization of nanoparticles for nanomedicine.Beating cancer in multiple ways using nanogold.Probing the inherent stability of siRNA immobilized on nanoparticle constructs.Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.Strategy for increasing drug solubility and efficacy through covalent attachment to polyvalent DNA-nanoparticle conjugates.Surface functionalization of gold nanoparticles with red blood cell membranesThe golden age: gold nanoparticles for biomedicine.Theranostic nanoshells: from probe design to imaging and treatment of cancer.Spherical nucleic acids as a divergent platform for synthesizing RNA-nanoparticle conjugates through enzymatic ligation.Size matters: gold nanoparticles in targeted cancer drug delivery.Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cellsGene Silencing of Human Neuronal Cells for Drug Addiction Therapy using Anisotropic NanocrystalsSelf-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer.Liposomal spherical nucleic acids.
P2860
Q21284977-D42558C2-CCFF-41E1-98E7-974C3DEE25E8Q26825775-5C84EC06-D2DE-4B1A-BB78-AA2DA7D4B6C4Q26851720-4980CC8B-B8E0-4490-8369-166D736D70DBQ27335339-C68067CD-DA9F-431E-87D6-408761D0F5D5Q28077290-FB885870-6B22-44E9-9FF9-05873E118F7DQ28255877-8A0D2427-5284-43AE-8AFC-C6AF66694253Q30374988-484E707E-0B42-4669-925D-E9248534B661Q30407973-ED0A269A-533D-4753-8E5E-A85CAF36F048Q30446963-099315B7-37B6-46A0-BDDB-01410FD11DA3Q30466993-2010904E-6234-4B8C-82F1-98D1980E77B9Q30540647-C1BE37E3-1B38-47D8-A779-0644E6B4806DQ30577878-1338D744-AF41-49FF-A98D-89B594A6F3F3Q30833380-24570F54-03AA-4A4B-948A-0B06260C2582Q33440795-AF57597F-8E6B-41DA-A97A-A9C519F6CCCFQ33506479-B10DAAEE-C382-473A-8983-72E9CEFA324BQ33558781-32EC837C-146B-469F-B959-92344746A420Q33593665-897E8CFE-60BE-4438-BA42-B93921C44943Q33648421-B14D180A-B718-423D-8EBF-C49D74573105Q33657117-9A1B5B0A-3453-4894-B83C-E2130FD573CAQ33713687-703C8B53-46D3-4377-9483-56E5627AA5E0Q33724219-EA825520-8ECE-4928-B15F-9DAEE8AB1124Q33744219-9BF8178D-CDD1-4408-9B8B-286FB16ED5C2Q33786171-A9CBE957-6C87-43FB-B187-B5355C63F37CQ33837834-4820F658-AE42-4B8D-9172-3FF735EDBED5Q33850611-3BE76DFF-0CAD-4EEB-8133-0A39C71B3361Q33914355-4DBB8A51-BD74-40EA-AF99-1ECCC92A6B3CQ33915941-502EB818-3BF0-4CFB-BFFF-2FC217503591Q33918483-824EC023-3851-4875-8817-2E26658EA6DCQ33919726-E0597909-E7A7-4403-8E65-57FDE12339A2Q33935474-929FE23F-3555-412A-BC30-171D9EA714E0Q33980411-926147D9-C6F3-4E4E-8B48-0D45CC0A3A93Q34067202-E9A32395-2765-437F-9E48-C1536F941483Q34081123-C31C663F-D886-47E0-9118-8B7EF683F64BQ34187209-5E165AD4-A752-4BE7-A72E-97E7D553EA51Q34239177-A33A4F0F-F200-43F7-8A0D-9C20981623E6Q34290392-6DF8F7DE-52CD-4903-AE86-985E0A812112Q34331704-6D6DE19C-EE32-4049-B6E0-5B210CDEDB4BQ34381259-831BE979-9B41-4CB8-AD18-2A77A2B893E7Q34617008-0F2E5499-2C65-423D-9D8C-9A693E3E1C71Q34789560-755318CD-B4F8-4FEB-9DA9-8BA41E4A8668
P2860
Gene regulation with polyvalent siRNA-nanoparticle conjugates
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Gene regulation with polyvalent siRNA-nanoparticle conjugates
@en
Gene regulation with polyvalent siRNA-nanoparticle conjugates.
@nl
type
label
Gene regulation with polyvalent siRNA-nanoparticle conjugates
@en
Gene regulation with polyvalent siRNA-nanoparticle conjugates.
@nl
prefLabel
Gene regulation with polyvalent siRNA-nanoparticle conjugates
@en
Gene regulation with polyvalent siRNA-nanoparticle conjugates.
@nl
P2093
P2860
P356
P1476
Gene regulation with polyvalent siRNA-nanoparticle conjugates
@en
P2093
Andrew E Prigodich
David A Giljohann
Pinal C Patel
P2860
P304
P356
10.1021/JA808719P
P407
P577
2009-02-01T00:00:00Z